Filter Results:
(258)
Show Results For
- All HBS Web
(120,178)
- Faculty Publications (258)
Show Results For
- All HBS Web
(120,178)
- Faculty Publications (258)
- April 2009
- Teaching Note
Amylin Pharmaceuticals: Diabetes and Beyond (TN)
By: Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011]. View Details
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- February 2009
- Teaching Note
Syndexa and Technology Transfer at Harvard University (TN)
Teaching Note for [808073]. View Details
- February 2009
- Teaching Note
Technology Transfer at U.S. Universities (TN)
Teaching Note for [807124]. View Details
Keywords: United States
- December 2008 (Revised October 2013)
- Case
Amylin Pharmaceuticals: Diabetes and Beyond (A)
By: Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details
Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Rachel Gordon. "Amylin Pharmaceuticals: Diabetes and Beyond (A)." Harvard Business School Case 809-011, December 2008. (Revised October 2013.)
- December 2008 (Revised April 2010)
- Case
Proteus Biomedical: Making Pigs Fly
By: Richard G. Hamermesh, Lauren Barley and Ginger Graham
Proteus is a healthcare start-up that has developed technology to embed electronics for computing and sensing in existing medical devices and drugs. The technology could potentially change the basis of competition in the pharmaceutical industry. The company is... View Details
Keywords: Business Startups; Entrepreneurship; Technological Innovation; Rights; Negotiation Deal; Business Strategy; Health Industry; Medical Devices and Supplies Industry; Pharmaceutical Industry
Hamermesh, Richard G., Lauren Barley, and Ginger Graham. "Proteus Biomedical: Making Pigs Fly." Harvard Business School Case 809-051, December 2008. (Revised April 2010.)
- November 2008 (Revised January 2010)
- Case
Stone Finch, Inc.: Young Division, Old Division
By: Richard G. Hamermesh and Elizabeth Collins
CEO Jim Billings wants to attract energetic, entrepreneurial talent to Stone Finch, Inc., which comprises an older division that fabricates products like piping and tanks for water and wastewater processing plants, and a much newer division that develops biochemical... View Details
Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Business Subsidiaries; Innovation Strategy; Resource Allocation; Organizational Structure; Organizational Culture; Retention; Operations; Recruitment; Integration; Business Growth and Maturation; Mergers and Acquisitions; Growth and Development Strategy; Manufacturing Industry
Hamermesh, Richard G., and Elizabeth Collins. "Stone Finch, Inc.: Young Division, Old Division." Harvard Business School Brief Case 083-214, November 2008. (Revised January 2010.)
- November 2008 (Revised January 2010)
- Teaching Note
Stone Finch, Inc.: Young Division, Old Division (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
Teaching Note for 3214 View Details
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Spreadsheet Supplement for Instructors (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Student Spreadsheet (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- April 2008
- Supplement
ProfitLogic (CW)
By: Lynda M. Applegate, Richard G. Hamermesh and Michael J. Roberts
This interactive spreadsheet accompanies the ProfitLogic case (#802-110) to enable analysis of the cash flow implications of three business models that the company is considering. Students are able to change key assumptions and see the impact on cash flow. View Details
- March 2008 (Revised June 2008)
- Case
Healthcare and Harvard Business School Alumni in 2008
By: Richard G. Hamermesh, Carin-Isabel Knoop and Cara Sterling
This case chronicles the role that Harvard Business School alumni play in the healthcare industry. Overall data on alumni is given, and the industry is broken into seven areas in which the careers of twenty-five alumni are highlighted. View Details
Keywords: Business Education; Executive Education; Personal Development and Career; Practice; Health Industry
Hamermesh, Richard G., Carin-Isabel Knoop, and Cara Sterling. "Healthcare and Harvard Business School Alumni in 2008." Harvard Business School Case 808-044, March 2008. (Revised June 2008.)
- February 2008
- Teaching Note
DermaCare: Zapping Zits Directly (TN)
Teaching Note for [808064]. View Details
- February 2008 (Revised January 2010)
- Teaching Note
Calloway Laboratory: Pee for Profit (TN)
Teaching Note for [807-040]. View Details
Keywords: Profit
- January 2008 (Revised January 2009)
- Teaching Note
Cynthia Fisher and the Rearing of ViaCell (TN)
By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
Teaching Note for [806002]. View Details
Keywords: Management
- October 2007
- Article
Realizing the Promise of Personalized Medicine
By: Mara G. Aspinall and Richard G. Hamermesh
Keywords: Health
Aspinall, Mara G., and Richard G. Hamermesh. "Realizing the Promise of Personalized Medicine." Harvard Business Review 85, no. 10 (October 2007).
- September 2007 (Revised October 2010)
- Case
DermaCare: Zapping Zits Directly
By: Richard G. Hamermesh and Lauren Barley
DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details
Keywords: Decision Choices and Conditions; Venture Capital; Investment; Innovation and Invention; Product; California
Hamermesh, Richard G., and Lauren Barley. "DermaCare: Zapping Zits Directly." Harvard Business School Case 808-064, September 2007. (Revised October 2010.)
- September 2007 (Revised May 2009)
- Case
Syndexa and Technology Transfer at Harvard University
By: Richard G. Hamermesh and David Kiron
Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the... View Details
Keywords: Business Startups; Higher Education; Entrepreneurship; Innovation and Invention; Intellectual Property; Rights; Agreements and Arrangements; Science-Based Business; Commercialization; Biotechnology Industry; Health Industry
Hamermesh, Richard G., and David Kiron. "Syndexa and Technology Transfer at Harvard University." Harvard Business School Case 808-073, September 2007. (Revised May 2009.)
- June 2007
- Teaching Note
Endo Pharmaceuticals Series (TN)
By: Richard G. Hamermesh, Brian DeLacey and Erin Seefeld
Keywords: Information